TY  - GEN 
AU  - Rand, K.
AU  - Ramos-Goñi, J. M.
AU  - Akmaz, B.
AU  - Solé-Feu, L.
AU  - Armario Hita, José Carlos
A4  - Medicina
PY  - 2024
SN  - 2190-9172
SN  - 2193-8210
UR  - http://hdl.handle.net/10498/32774
AB  - Letter
LA  - eng
PB  - Adis
TI  - Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”
DO  - https://doi.org/10.1007/s13555-024-01106-2
ER  -